Evidence map›Paper›PMID 29085303›Full record

ArticleFrontiers in physiology2017

Presenilin 2-Dependent Maintenance of Mitochondrial Oxidative Capacity and Morphology.

Sabrina Contino, Paolo E Porporato, Matthew Bird, Claudia Marinangeli, Rémi Opsomer, Pierre Sonveaux, Françoise Bontemps, Ilse Dewachter, Jean-Noël Octave, Luc Bertrand and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Cachexia, a Systemic Disease beyond Muscle Atrophy.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sabrina ContinoAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
Paolo E PorporatoPharmacology and Therapeutics, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
Matthew BirdAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
Claudia MarinangeliAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
Rémi OpsomerAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
Pierre SonveauxPharmacology and Therapeutics, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
Françoise BontempsMetabolic Research Group, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Ilse DewachterAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
Jean-Noël OctaveAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
Luc BertrandPole of Cardiovascular Research, Institute of Experimental and clinical Research, Université catholique de Louvain, Brussels, Belgium.
Serena StangaAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
Pascal Kienlen-CampardAlzheimer Research Group, Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.
UCLouvain · BEde Duve Institute · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial dysfunction plays a pivotal role in the progression of Alzheimer's disease (AD), and yet the mechanisms underlying the impairment of mitochondrial function in AD remain elusive. Recent evidence suggested a role for Presenilins (PS1 or PS2) in mitochondrial function. Mutations of PSs, the catalytic subunits of the γ-secretase complex, are responsible for the majority of inherited AD cases (FAD). PSs were shown to be present in mitochondria and particularly enriched in mitochondria-associated membranes (MAM), where PS2 is involved in the calcium shuttling between mitochondria and the endoplasmic reticulum (ER). We investigated the precise contribution of PS1 and PS2 to the bioenergetics of the cell and to mitochondrial morphology in cell lines derived from wild type (PS+/+), PS1/2 double knock-out (PSdKO), PS2KO and PS1KO embryos. Our results showed a significant impairment in the respiratory capacity of PSdKO and PS2KO cells with reduction of basal oxygen consumption, oxygen utilization dedicated to ATP production and spare respiratory capacity. In line with these functional defects, we found a decrease in the expression of subunits responsible for mitochondrial oxidative phosphorylation (OXPHOS) associated with an altered morphology of the mitochondrial cristae. This OXPHOS disruption was accompanied by a reduction of the NAD

Indexed as

Alzheimer's diseasecellular bioenergeticsglycolysismitochondriaoxidative phosphorylationpresenilin

Identifiers

PMID29085303
PMCPMC5650731
OpenAlexW2761646800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.